PIRMELLA Drug Patent Profile
✉ Email this page to a colleague
When do Pirmella patents expire, and when can generic versions of Pirmella launch?
Pirmella is a drug marketed by Lupin Ltd and is included in two NDAs.
The generic ingredient in PIRMELLA is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PIRMELLA?
- What are the global sales for PIRMELLA?
- What is Average Wholesale Price for PIRMELLA?
Summary for PIRMELLA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for PIRMELLA |
| Drug Sales Revenues: | Drug sales revenues for PIRMELLA |
| DailyMed Link: | PIRMELLA at DailyMed |
US Patents and Regulatory Information for PIRMELLA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | PIRMELLA 1/35 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 201512-001 | Apr 24, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lupin Ltd | PIRMELLA 7/7/7 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 201510-001 | Apr 24, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
